Monoclonal gammopathy of renal significance (MGRS): retrospective monocentric analysis of clinical outcomes and treatment strategies.

Summary: Imagine your body making abnormal proteins that act like tiny wrecking balls, specifically targeting your kidneys. This rare condition is called MGRS. Doctors looked back at 34 patients with this disease to see how they were doing and what treatments worked best. They found the disease generally falls into two types: one that causes widespread kidney damage (MGRS-A) and another that attacks specific filtering parts of the kidney (MGRS-NA). Doctors used powerful drugs to target the bad cells making these proteins. While both groups had similar overall survival rates, the widespread type (MGRS-A) moved much faster and was more aggressive. The most common side effect of treatment was anemia. This study shows why doctors need better guidelines to catch and treat this rare kidney disease early.